联合炼计划对接受化疗的乳腺癌患者疲劳严重性的影响:一项随机临床试验研究
Elahe Darvishi1, Amir Musarezaie1, Masoud Bahrami2
1Department of Adult Health Nursing, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
Iranian journal of nursing and midwifery research
|September 11, 2023
概括
联合炼计划显著降低了接受化疗的乳腺癌患者的疲劳强度. 这种干预提供了一种补充方法,以改善癌症患者的生活质量.
科学领域:
- 在瘤学瘤学.
- 运动生理学 运动生理学
- 临床试验 临床试验
背景情况:
- 乳腺癌 (BC) 是全球和伊朗普遍存在的恶性瘤.
- 化疗是一种标准的BC治疗,通常会导致显著的副作用,特别是疲劳.
- 这项研究解决了在BC患者中缓解化疗诱导疲劳的干预措施的需要.
研究的目的:
- 评估联合炼计划在接受化疗的乳腺癌患者中减少疲劳强度的有效性.
- 为整合运动作为癌症治疗中的补充疗法提供证据.
主要方法:
- 一项随机临床试验,涉及64名接受化疗的乳腺癌患者.
- 参与者被分配到干预 (联合炼) 或对照组.
- 干预组参与了为期8周的计划,每周进行3次运动 (35-40分钟).
- 派珀疲劳量表被用于干预前后的评估.
主要成果:
- 与对照组相比,干预组观察到疲劳强度的统计显著减少 (p = 0.004).
- 在干预组中,平均疲劳强度得分从8.17 (SD 1.88) 降至5.56 (SD 1.74).
- 这些发现表明,联合炼计划对减轻患者疲劳有很大的影响.
结论:
- 联合炼计划在接受化疗的乳腺癌患者减轻疲劳方面是有效的.
- 护士可以将运动干预作为补充医学,以提高癌症患者的生活质量.
- 运动代表了一种有价值的非药物治疗策略,用于在瘤护理中管理治疗副作用.
相关概念视频
Muscle Recovery and Fatigue
2.2K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.2K
Fatigue
204
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
204
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Exercise and Cardiovascular Response
856
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
856
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


